Kenichi Kawasaki

Person

Fujisawa, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Arylamide derivative having antitumor activity
- Patent number 11,964,950
- Issue date Apr 23, 2024
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Yoshiaki Isshiki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine ether derivatives as NK3 receptor antagonists
- Patent number 8,063,075
- Issue date Nov 22, 2011
- Hoffmann-La Roche Inc.
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediate compound for synthesis of viridiofungin a derivative
- Patent number 8,030,496
- Issue date Oct 4, 2011
- Chugai Seiyaki Kabushiki Kaisha
- Tatsuya Kato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine aryl-ether as NK-3 receptor antagonists
- Patent number 8,012,998
- Issue date Sep 6, 2011
- Hoffmann-La Roche Inc.
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Intermediate compound for synthesis of viridiofungin a derivative
- Patent number 7,897,783
- Issue date Mar 1, 2011
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tatsuya Kato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine aryl-ether as NK3 receptor antagonists
- Patent number 7,812,021
- Issue date Oct 12, 2010
- Hoffmann-La Roche Inc.
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Remedy for viral disease
- Patent number 7,776,918
- Issue date Aug 17, 2010
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Masahiro Aoki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound having anti-HCV activity and process for producing the same
- Patent number 7,378,446
- Issue date May 27, 2008
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Masayuki Sudoh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polycyclic compounds exhibiting anti-tumor activities
- Patent number 6,946,472
- Issue date Sep 20, 2005
- Hoffman-La Roche Inc.
- Kenichi Kawasaki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polycyclic compounds
- Patent number 6,680,326
- Issue date Jan 20, 2004
- Hoffmann-La Roche Inc.
- Tsunehisa Aoyama
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic compounds
- Patent number 6,376,491
- Issue date Apr 23, 2002
- Basilea Pharmaceutica AG
- Yuhko Aoki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY
- Publication number 20240246922
- Publication date Jul 25, 2024
- Chugai SeiYaku Kabushiki Kaisha
- Yoshiaki Isshiki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY
- Publication number 20230002333
- Publication date Jan 5, 2023
- Chugai SeiYaku Kabushiki Kaisha
- Yoshiaki Isshiki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Virus therapeutic drug
- Publication number 20100274026
- Publication date Oct 28, 2010
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Masahiro Aoki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Intermediate compound for synthesis of viridiofungin a derivative
- Publication number 20100152457
- Publication date Jun 17, 2010
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tatsuya Kato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Intermediate compound for synthesis of viridiofungin a derivative
- Publication number 20100152456
- Publication date Jun 17, 2010
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tatsuya Kato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS
- Publication number 20090306043
- Publication date Dec 10, 2009
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS
- Publication number 20090054644
- Publication date Feb 26, 2009
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS
- Publication number 20090042896
- Publication date Feb 12, 2009
- Philippe Jablonski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Production Process of Compound Having Anti-Hcv Action and Intermedi...
- Publication number 20080293950
- Publication date Nov 27, 2008
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tatsuya Kato
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Remedy for viral disease
- Publication number 20060217434
- Publication date Sep 28, 2006
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Masahiro Aoki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compound having anti-hcv activity and process for producing the same
- Publication number 20060194870
- Publication date Aug 31, 2006
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Masayuki Sudoh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polycyclic compounds exhibiting anti-tumor activities
- Publication number 20030229098
- Publication date Dec 11, 2003
- Kenichi Kawasaki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polycyclic compounds
- Publication number 20030073691
- Publication date Apr 17, 2003
- Tsunehisa Aoyama
- C07 - ORGANIC CHEMISTRY

Kenichi Kawasaki

Person

Patents Grantslast 30 patents

Arylamide derivative having antitumor activity

Pyrrolidine ether derivatives as NK3 receptor antagonists

Intermediate compound for synthesis of viridiofungin a derivative

Pyrrolidine aryl-ether as NK-3 receptor antagonists

Intermediate compound for synthesis of viridiofungin a derivative

Pyrrolidine aryl-ether as NK3 receptor antagonists

Remedy for viral disease

Compound having anti-HCV activity and process for producing the same

Polycyclic compounds exhibiting anti-tumor activities

Polycyclic compounds

Bicyclic compounds

Patents Applicationslast 30 patents

ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY

ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY

Virus therapeutic drug

Intermediate compound for synthesis of viridiofungin a derivative

Intermediate compound for synthesis of viridiofungin a derivative

PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS

PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS

PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS

Production Process of Compound Having Anti-Hcv Action and Intermedi...

Remedy for viral disease

Compound having anti-hcv activity and process for producing the same

Polycyclic compounds exhibiting anti-tumor activities

Polycyclic compounds